US Stock MarketDetailed Quotes

HRTX Heron Therapeutics

Watchlist
  • 1.780
  • +0.040+2.30%
Close Nov 1 16:00 ET
  • 1.740
  • -0.040-2.25%
Post 20:02 ET
269.97MMarket Cap-7120P/E (TTM)

Heron Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
13.42%36.02M
17.07%34.67M
17.99%127.04M
14.00%34.23M
18.36%31.43M
14.95%31.76M
26.25%29.62M
24.70%107.67M
45.38%30.03M
14.32%26.56M
Operating revenue
13.42%36.02M
17.07%34.67M
17.99%127.04M
14.00%34.23M
18.36%31.43M
14.95%31.76M
26.25%29.62M
24.70%107.67M
45.38%30.03M
14.32%26.56M
Cost of revenue
-47.82%10.52M
-49.90%8.44M
18.64%65.11M
-21.72%9.89M
23.72%18.21M
24.62%20.16M
48.43%16.85M
19.24%54.87M
15.41%12.63M
29.65%14.72M
Gross profit
119.80%25.51M
105.52%26.23M
17.31%61.94M
39.92%24.35M
11.71%13.23M
1.30%11.6M
5.45%12.76M
30.93%52.8M
79.13%17.4M
-0.33%11.84M
Operating expense
-40.84%31.95M
-32.30%31.02M
-24.14%172.55M
-8.44%34.57M
-28.98%38.16M
-11.40%54.01M
-38.92%45.82M
-11.89%227.46M
-40.31%37.76M
-15.51%53.72M
Selling and administrative expenses
-32.55%27.52M
-28.58%26.42M
-2.75%116.66M
-11.54%23.62M
-12.71%24.6M
27.02%40.8M
12.24%36.99M
-5.80%119.95M
-22.33%26.7M
-19.48%28.18M
-Selling and marketing expense
-35.80%13.61M
-45.91%11.44M
-18.02%67.64M
-30.64%12.33M
-29.50%12.96M
-7.56%21.21M
-9.68%21.15M
-5.35%82.51M
-27.41%17.78M
-27.09%18.38M
-General and administrative expense
-29.03%13.91M
-5.43%14.97M
30.92%49.01M
26.51%11.29M
18.80%11.64M
113.40%19.59M
66.10%15.83M
-6.76%37.44M
-9.74%8.92M
0.13%9.8M
Research and development costs
-66.45%4.43M
-47.85%4.61M
-48.01%55.9M
-0.97%10.95M
-46.93%13.56M
-54.19%13.21M
-79.00%8.84M
-17.82%107.51M
-61.71%11.06M
-10.67%25.55M
Operating profit
84.80%-6.45M
85.49%-4.8M
36.67%-110.62M
49.79%-10.22M
40.48%-24.93M
14.33%-42.4M
47.45%-33.06M
19.82%-174.66M
61.98%-20.36M
19.00%-41.88M
Net non-operating interest income expense
39.71%-504K
57.71%-836K
Non-operating interest income
----
----
105.37%3.36M
----
----
----
----
278.29%1.64M
----
----
Non-operating interest expense
----
----
56.35%3.87M
----
----
----
----
2.66%2.47M
----
----
Other net income (expense)
-911.05%-2.79M
455.25%1.64M
108.58%560K
0
-203.85%-79K
105.01%344K
130.57%295K
-643.74%-6.53M
52.30%1.32M
96.29%-26K
Other non- operating income (expenses)
-911.05%-2.79M
455.25%1.64M
108.58%560K
--0
-203.85%-79K
105.01%344K
130.57%295K
-643.74%-6.53M
52.30%1.32M
96.29%-26K
Income before tax
78.04%-9.24M
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
17.52%-182.02M
63.64%-19.87M
20.04%-41.91M
Income tax
Net income
78.04%-9.24M
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
17.52%-182.02M
63.64%-19.87M
20.04%-41.91M
Net income continuous Operations
78.04%-9.24M
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
17.52%-182.02M
63.64%-19.87M
20.04%-41.91M
Minority interest income
Net income attributable to the parent company
78.04%-9.24M
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
17.52%-182.02M
63.64%-19.87M
20.04%-41.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
78.04%-9.24M
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
17.52%-182.02M
63.64%-19.87M
20.04%-41.91M
Basic earnings per share
82.86%-0.06
92.59%-0.02
52.10%-0.8
70.59%-0.05
55.26%-0.17
36.36%-0.35
57.14%-0.27
25.45%-1.67
68.52%-0.17
25.49%-0.38
Diluted earnings per share
82.86%-0.06
92.59%-0.02
52.10%-0.8
70.59%-0.05
55.26%-0.17
36.36%-0.35
57.14%-0.27
25.45%-1.67
68.52%-0.17
25.49%-0.38
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 13.42%36.02M17.07%34.67M17.99%127.04M14.00%34.23M18.36%31.43M14.95%31.76M26.25%29.62M24.70%107.67M45.38%30.03M14.32%26.56M
Operating revenue 13.42%36.02M17.07%34.67M17.99%127.04M14.00%34.23M18.36%31.43M14.95%31.76M26.25%29.62M24.70%107.67M45.38%30.03M14.32%26.56M
Cost of revenue -47.82%10.52M-49.90%8.44M18.64%65.11M-21.72%9.89M23.72%18.21M24.62%20.16M48.43%16.85M19.24%54.87M15.41%12.63M29.65%14.72M
Gross profit 119.80%25.51M105.52%26.23M17.31%61.94M39.92%24.35M11.71%13.23M1.30%11.6M5.45%12.76M30.93%52.8M79.13%17.4M-0.33%11.84M
Operating expense -40.84%31.95M-32.30%31.02M-24.14%172.55M-8.44%34.57M-28.98%38.16M-11.40%54.01M-38.92%45.82M-11.89%227.46M-40.31%37.76M-15.51%53.72M
Selling and administrative expenses -32.55%27.52M-28.58%26.42M-2.75%116.66M-11.54%23.62M-12.71%24.6M27.02%40.8M12.24%36.99M-5.80%119.95M-22.33%26.7M-19.48%28.18M
-Selling and marketing expense -35.80%13.61M-45.91%11.44M-18.02%67.64M-30.64%12.33M-29.50%12.96M-7.56%21.21M-9.68%21.15M-5.35%82.51M-27.41%17.78M-27.09%18.38M
-General and administrative expense -29.03%13.91M-5.43%14.97M30.92%49.01M26.51%11.29M18.80%11.64M113.40%19.59M66.10%15.83M-6.76%37.44M-9.74%8.92M0.13%9.8M
Research and development costs -66.45%4.43M-47.85%4.61M-48.01%55.9M-0.97%10.95M-46.93%13.56M-54.19%13.21M-79.00%8.84M-17.82%107.51M-61.71%11.06M-10.67%25.55M
Operating profit 84.80%-6.45M85.49%-4.8M36.67%-110.62M49.79%-10.22M40.48%-24.93M14.33%-42.4M47.45%-33.06M19.82%-174.66M61.98%-20.36M19.00%-41.88M
Net non-operating interest income expense 39.71%-504K57.71%-836K
Non-operating interest income --------105.37%3.36M----------------278.29%1.64M--------
Non-operating interest expense --------56.35%3.87M----------------2.66%2.47M--------
Other net income (expense) -911.05%-2.79M455.25%1.64M108.58%560K0-203.85%-79K105.01%344K130.57%295K-643.74%-6.53M52.30%1.32M96.29%-26K
Other non- operating income (expenses) -911.05%-2.79M455.25%1.64M108.58%560K--0-203.85%-79K105.01%344K130.57%295K-643.74%-6.53M52.30%1.32M96.29%-26K
Income before tax 78.04%-9.24M90.36%-3.16M39.26%-110.56M46.03%-10.72M40.33%-25.01M25.37%-42.06M48.71%-32.77M17.52%-182.02M63.64%-19.87M20.04%-41.91M
Income tax
Net income 78.04%-9.24M90.36%-3.16M39.26%-110.56M46.03%-10.72M40.33%-25.01M25.37%-42.06M48.71%-32.77M17.52%-182.02M63.64%-19.87M20.04%-41.91M
Net income continuous Operations 78.04%-9.24M90.36%-3.16M39.26%-110.56M46.03%-10.72M40.33%-25.01M25.37%-42.06M48.71%-32.77M17.52%-182.02M63.64%-19.87M20.04%-41.91M
Minority interest income
Net income attributable to the parent company 78.04%-9.24M90.36%-3.16M39.26%-110.56M46.03%-10.72M40.33%-25.01M25.37%-42.06M48.71%-32.77M17.52%-182.02M63.64%-19.87M20.04%-41.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 78.04%-9.24M90.36%-3.16M39.26%-110.56M46.03%-10.72M40.33%-25.01M25.37%-42.06M48.71%-32.77M17.52%-182.02M63.64%-19.87M20.04%-41.91M
Basic earnings per share 82.86%-0.0692.59%-0.0252.10%-0.870.59%-0.0555.26%-0.1736.36%-0.3557.14%-0.2725.45%-1.6768.52%-0.1725.49%-0.38
Diluted earnings per share 82.86%-0.0692.59%-0.0252.10%-0.870.59%-0.0555.26%-0.1736.36%-0.3557.14%-0.2725.45%-1.6768.52%-0.1725.49%-0.38
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data